Monday, June 11, 2012
Correction: Diabetes Drugs story
Forward Print Share Single Page
Vote on It:
Average Vote:
[+] Text [-]
 
 

In a June 10 story about diabetes treatment research, The Associated Press reported erroneously that LY2605541 is a short-acting insulin. It is a long-acting insulin.

Also, Johnson & Johnson applied for U.S. approval to sell its experimental diabetes pill canagliflozin on May 31, not May 29.
Share:
Forward Print Single Page
Vote on It:
Average Vote:
 

Join The Debate!

Post Your Comment
(0 comments so Far)
View in ascending order     View in descending order
Sign Up to Post Your CommentsSign Up to Post Your Comments
If you are already registered, click here to login. Otherwise, please take a few seconds to register with Townhall.com. Once you sign up, you’ll be able to post your comments immediately, use the action center, get podcasts, and more!
Note: Fields marked with a red asterisk (*) are required.
Salutation:
First Name:
*
Last Name:
*
Email:
*
Nickname:
*
Note: Nick name will be shown when you post comments.
Address 1:
*
Address 2:
City:
 *
State:
 *
Zip:
 *
Phone:
       
 
Partners:
Townhall.com :: Where Your Opinion Counts
Oneplace.com
Crosswalk.com
LightSource.com
go
All Audio Video
About Us | Become a Partner | Privacy Policy | Terms of Use | Advertise | Radio Stations
Copyright © 2013 Salem Web Network. All Rights Reserved. Terms under which this service is provided to you
Contact us via email
6400 N. Beltline Rd | Suite 210 | Irving, TX 75063